dukederm.duke.edu  
   
Active Clinical Trials
| CTCL Trials | Hair Trials
| Blistering Disorders | Psoriasis Trials
1. CTCL: PUVA vs Targretin/PUVA in patients with stage IA-IIA CTCL.
 
2. CTCL: Oral forodesin hydrochloride in stage 1b-IV refractory CTCL.
 
3. CTCL: HuMax-CD4 in patients with Mycosis Fungoides type CTCL (Stage lb-lVb) who are refractory or Intolerant to Targretin and one other standard therapy.
Printer Friendly Page Send this Story to a Friend
Disclaimer      Duke & Your Privacy      © 2009, Duke University Health System  
DHTS Strategic Web Services DHTS STRATEGIC WEB SERVICES